These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31384747)

  • 1. Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine.
    Mvundura M; Hsu JS; Frivold C; Kristensen D; Boyle S; Zehrung D; Jarrahian C
    Vaccine X; 2019 Aug; 2():100032. PubMed ID: 31384747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule.
    Anand A; Molodecky NA; Pallansch MA; Sutter RW
    Vaccine; 2017 May; 35(22):2993-2998. PubMed ID: 28434691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of full and fractional dose of inactivated poliovirus vaccine for use in routine immunisation and outbreak response: an open-label, randomised controlled trial.
    Snider CJ; Zaman K; Estivariz CF; Yunus M; Weldon WC; Wannemuehler KA; Oberste MS; Pallansch MA; Wassilak SG; Bari TIA; Anand A
    Lancet; 2019 Jun; 393(10191):2624-2634. PubMed ID: 31104832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.
    Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R
    Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.
    Jaiswal N; Singh S; Agarwal A; Chauhan A; Thumburu KK; Kaur H; Singh M
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011780. PubMed ID: 31858595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV).
    Jarrahian C; Rein-Weston A; Saxon G; Creelman B; Kachmarik G; Anand A; Zehrung D
    Vaccine; 2017 Mar; 35(14):1789-1796. PubMed ID: 28189403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey.
    Trueba G; Jeyaseelan V; Lopez L; Mainou BA; Zhang Y; Whittembury A; Valarezo AJO; Baquero G; de Aguinaga RR; Salinas LJZ; Mancheno MGS; Chacho DEM; Quentin E; Chevez AE; Rey-Benito G; Mach O
    Lancet Reg Health Am; 2022 Jul; 11():None. PubMed ID: 35865654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India.
    Ahmad M; Verma H; Deshpande J; Kunwar A; Bavdekar A; Mahantashetti NS; Krishnamurthy B; Jain M; Mathew MA; Pawar SD; Sharma DK; Sethi R; Visalakshi J; Mohanty L; Bahl S; Haldar P; Sutter RW
    J Pediatric Infect Dis Soc; 2022 Feb; 11(2):60-68. PubMed ID: 34791350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractional-Dose Inactivated Poliovirus Vaccine Immunization Campaign - Telangana State, India, June 2016.
    Bahl S; Verma H; Bhatnagar P; Haldar P; Satapathy A; Kumar KN; Horton J; Estivariz CF; Anand A; Sutter R
    MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(33):859-63. PubMed ID: 27559683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis.
    Mashunye TR; Ndwandwe DE; Dube KR; Shey M; Shelton M; Wiysonge CS
    Lancet Infect Dis; 2021 Aug; 21(8):1161-1174. PubMed ID: 33939958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
    Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM
    Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity.
    Resik S; Tejeda A; Mach O; Sein C; Molodecky N; Jarrahian C; Saganic L; Zehrung D; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter RW
    Vaccine; 2015 Oct; 33(43):5873-5877. PubMed ID: 26192350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of Intramuscular Fractional Dose of Inactivated Poliovirus Vaccine.
    Resik S; Mach O; Tejeda A; Jeyaseelan V; Fonseca M; Diaz M; Alemany N; Hung LH; Aleman Y; Mesa I; Garcia G; Sutter RW
    J Infect Dis; 2020 Mar; 221(6):895-901. PubMed ID: 31242300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh, Pakistan.
    Bullo UF; Mehraj J; Raza SM; Rasool S; Ansari NN; Shaikh AA; Phul ZA; Memon SA; Baloch RI; Baloch ZA; Chandio SA
    BMC Public Health; 2021 Jan; 21(1):44. PubMed ID: 33407294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh.
    Aziz AB; Verma H; Jeyaseelan V; Yunus M; Nowrin S; Moore DD; Mainou BA; Mach O; Sutter RW; Zaman K
    J Infect Dis; 2022 Oct; 226(8):1319-1326. PubMed ID: 35575051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia.
    Bashorun AO; Badjie Hydara M; Adigweme I; Umesi A; Danso B; Johnson N; Sambou NA; Fofana S; Kanu FJ; Jeyaseelan V; Verma H; Weldon WC; Oberste MS; Sutter RW; Jeffries D; Wathuo M; Mach O; Clarke E
    Lancet Glob Health; 2022 Feb; 10(2):e257-e268. PubMed ID: 34951974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization.
    Okayasu H; Sein C; Chang Blanc D; Gonzalez AR; Zehrung D; Jarrahian C; Macklin G; Sutter RW
    J Infect Dis; 2017 Jul; 216(suppl_1):S161-S167. PubMed ID: 28838185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boosting of Mucosal Immunity After Fractional-Dose Inactivated Poliovirus Vaccine.
    Gamage D; Mach O; Palihawadana P; Zhang Y; Weldon WC; Oberste MS; Gunasena S; Sutter RW
    J Infect Dis; 2018 Nov; 218(12):1876-1882. PubMed ID: 29982532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka.
    Gamage D; Mach O; Ginige S; Weldon WC; Oberste MS; Jeyaseelan V; Sutter RW
    J Infect Dis; 2019 May; 219(12):1887-1892. PubMed ID: 30649505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.